Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria

医学 宫颈癌 核医学 颈淋巴结 淋巴 放射科 医学物理学 癌症 内科学 病理 转移
作者
J. E. Snyder,A. Willett,Wenqing Sun,Yusung Kim
出处
期刊:Practical radiation oncology [Elsevier BV]
卷期号:9 (2): e156-e163 被引量:5
标识
DOI:10.1016/j.prro.2018.10.012
摘要

This study aimed to examine the feasibility of stereotactic body radiation therapy (SBRT) as an external beam radiation therapy boost to positron emission tomography (PET) positive lymph nodes (LN) in patients with cervical cancer and to evaluate overall tumor control probability (TCP) increase.Ten patients with cervical cancer and PET positive LN metastasis who received external beam radiation therapy (45 Gy), followed by a 3-dimensional conformal radiation therapy boost (5.4-9 Gy) and tandem-and-ovoid high-dose-rate brachytherapy (16-30 Gy) were retrospectively enrolled in this study. SBRT plans were generated using 21 Gy, 24 Gy, or 30 Gy as a replacement for 3-dimensional conformal radiation therapy boost. The 2 Gy-per-fraction equivalent dose maps were made using an α/β value of 10 for PET positive LNs and 3 for organs at risk (OARs). TCP values were calculated using a logistic TCP model, where 2 input parameters (D50 and Gamma50 = 2) were modeled by 2 clinical outcomes: our institution and the literature. OAR sparing was evaluated using Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC) dose limits.Thirty percent of 10 patients receiving conventional boost experienced recurrence. The TCP of the SBRT schemes was 88% ± 7% (97% ± 2%; 21 Gy), 96% ± 1% (99% ± 0%; 24 Gy), and 99% ± 1% (100% ± 0%; 30 Gy), and the conventional LN-boost TCP value was 25% ± 11% (58% ± 15%) when TCP input parameters were based on published clinical outcome data for LN SBRT treatments (institutional outcome data). The tumor coverage doses (D90) of the SBRT boost plans were on average 32.34 Gyαβ=10 (21 Gy), 37.78 Gyαβ=10 (24 Gy), and 55.54Gyαβ=10 (30 Gy) higher than the conventional LN boost plan. The QUANTEC OAR dose constraints were met for the bladder, rectum, and bowel in all cases for the SBRT LN 21 Gy group, and in 90% and 70% of cases in the SBRT LN 24 Gy and SBRT LN 30 Gy groups, respectively.An SBRT boost dose of 30 Gy can be delivered without compromising QUANTEC OAR limits. The use of SBRT increases TCP values, regardless of the input parameters.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
来福完成签到,获得积分20
3秒前
脑洞疼应助yun采纳,获得10
4秒前
李123发布了新的文献求助10
5秒前
hhhhxxxx完成签到,获得积分10
8秒前
Silole完成签到,获得积分10
11秒前
13秒前
13秒前
能干梦琪完成签到 ,获得积分10
14秒前
14秒前
fjq95133完成签到 ,获得积分10
14秒前
17秒前
李123完成签到,获得积分10
17秒前
突突突发布了新的文献求助10
17秒前
swordlee发布了新的文献求助30
18秒前
多多发布了新的文献求助10
18秒前
好好完成签到,获得积分10
19秒前
xwx完成签到,获得积分10
21秒前
yun发布了新的文献求助10
21秒前
CharlieYue完成签到,获得积分10
25秒前
yun完成签到,获得积分10
26秒前
研友_8Y2DXL完成签到,获得积分10
31秒前
yue完成签到 ,获得积分10
32秒前
Lucycomplex完成签到,获得积分10
35秒前
方百招完成签到,获得积分10
35秒前
41秒前
小张完成签到,获得积分10
46秒前
46秒前
小高完成签到 ,获得积分10
46秒前
zjiayouz发布了新的文献求助10
47秒前
舒心的曲奇完成签到,获得积分10
48秒前
zh1858f完成签到,获得积分10
50秒前
Riverchase应助科研通管家采纳,获得30
57秒前
57秒前
57秒前
57秒前
xzy998应助科研通管家采纳,获得10
57秒前
爆米花应助科研通管家采纳,获得10
57秒前
xzy998应助科研通管家采纳,获得10
57秒前
xzy998应助科研通管家采纳,获得10
57秒前
59秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Signals, Systems, and Signal Processing 610
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
Photodetectors: From Ultraviolet to Infrared 500
On the Dragon Seas, a sailor's adventures in the far east 500
Yangtze Reminiscences. Some Notes And Recollections Of Service With The China Navigation Company Ltd., 1925-1939 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6355811
求助须知:如何正确求助?哪些是违规求助? 8170527
关于积分的说明 17201160
捐赠科研通 5411774
什么是DOI,文献DOI怎么找? 2864385
邀请新用户注册赠送积分活动 1841922
关于科研通互助平台的介绍 1690224